RT Journal Article
SR Electronic
T1 Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e003777
DO 10.1136/jitc-2021-003777
VO 10
IS 1
A1 Oaknin, Ana
A1 Gilbert, Lucy
A1 Tinker, Anna V
A1 Brown, Jubilee
A1 Mathews, Cara
A1 Press, Joshua
A1 Sabatier, Renaud
A1 O’Malley, David M
A1 Samouelian, Vanessa
A1 Boni, Valentina
A1 Duska, Linda
A1 Ghamande, Sharad
A1 Ghatage, Prafull
A1 Kristeleit, Rebecca
A1 Leath III, Charles
A1 Guo, Wei
A1 Im, Ellie
A1 Zildjian, Sybil
A1 Han, Xinwei
A1 Duan, Tao
A1 Veneris, Jennifer
A1 Pothuri, Bhavana
YR 2022
UL http://jitc.bmj.com/content/10/1/e003777.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.